Patent Landscape Report on Ritonavir - WIPO

More documents

Recommendations

Info

The WIPO patent landscape report projectis based on the Development Agenda projectDA_19_30_31_01 (“Developing Tools forAccess to <strong>Patent</strong> Information”) described indocument CDIP/4/6, adopted by the Committeeon Development and IntellectualProperty (CDIP) at its fourth session heldfrom November 16 to November 20, 2009.The purpose of each report is three-fold:- It attempts to research and describe thepatterns of patenting and innovation activityrelated to specific technologies in variousdomains such as health, food and agriculture,climate change related technologies,and others.- WIPO attempts to collaborate for each reportwith institutional partners (IGOs,NGOs, public institutions) working in therespective field and having an interest in aspecific topic. The collaborative work in theplanning and evaluation phase may alsoserve as a vehicle for these institutions tofamiliarize themselves with the utilizationand exploitation of patent information andrelated issues of patent protection. WIPOwelcomes proposals for collaboration.- Each report also serves as an illustrativeexample for retrieving patent information inthe respective field and how search strategiesmay be tailored accordingly. It thereforeincludes detailed explanations of theparticular search methodology, the databasesused and well documented searchqueries that should ideally enable thereader to conduct a similar search.Each report of this project is contracted outto an external firm selected in a tenderingprocedure. The tender is open to a limitednumber of bidders that were preselectedbased on their submission of an Expressionof Interest (EOI). WIPO invites the submissionof further EOIs by qualified providers.More information on the project, the ongoingwork, and a compilation of reports publishedalso by other institutions is availableat: www.wipo.int/patentscope/en/programs/patent_landscapes/pl_about.htmlFor specific information, requests or proposals,please contact us(patent.information@wipo.int)
<strong>Patent</strong> <strong>Landscape</strong> <strong>Report</strong> onRitonavirPrepared for:World Intellectual Property OrganizationPrepared by:Landon IPOctober 28, 2011
Page 1: Patent Lan
Page 6 and 7: STN- Transcript of Search History .
Page 8 and 9: priority to an earlier Italian pate
Page 10 and 11: Section 2 - Search Process2.1 Intro
Page 12 and 13: these documents differed from WO199
Page 14 and 15: prevented along with compound names
Page 16 and 17: Section 3 - Statistical Analysis3.1
Page 18 and 19: Figure 2 shows that the overall pat
Page 20 and 21: Figures 4 and 5 show the most commo
Page 22 and 23: Figure 6 illustrates the percentage
Page 24 and 25: Figure 8 shows the distribution of
Page 26 and 27: Patent AuthorityNu
Page 28 and 29: Figure 11a: Geographic distribution
Page 30 and 31: PatentAuthorityNum
Page 32 and 33: Figure 14 shows the most common inv
Page 34 and 35: Intellixir was used in concert with
Page 36 and 37: 4.1.2 Brief description of innovati
Page 38 and 39: The fourth innovation track focuses
Page 40 and 41: portant because of the thermal inst
Page 42 and 43: 4.2.2 Innovation track 2: Synthesis
Page 44 and 45: the Synthesis of Ritonavir Innovati
Page 46 and 47: several different ways. This partic
Page 48 and 49: 4.2.4 Innovation track 4: Solid Dos
Page 50 and 51: The broad independent claim languag
Page 52 and 53:
are cited by more than one other do
Page 54 and 55:
US6765019 cites WO9404193 (describe
Page 56 and 57:
WO9933815. Also, the ‘869 documen
Page 58 and 59:
Section 5 - Report
Page 60 and 61:
AppendicesAppendix 1 - Innovation T
Page 62 and 63:
1.3 Polymorphs
Page 64 and 65:
1.5 Prodrugs of RitonavirInnovation
Page 66 and 67:
ECLA Classification System: ECLA st
Page 68 and 69:
Appendix 3 - Ritonavir Pate
Page 70 and 71:
US4725583 OR US4725584 OR US4826815
Page 72 and 73:
US2010009970 OR US7785879 OR US7700
Page 74 and 75:
US2005084529 OR US2005079200 OR US2
Page 76 and 77:
"HOFFMANN_LA_ROCHE_F_AND_CO_A_G" OR
Page 78 and 79:
"A61K9/50" OR "A61K9/52" OR "A61K9/
Page 80 and 81:
WO08051039 OR US2006205697 OR WO050
Page 82 and 83:
WO09045975 OR US2009226431 OR WO071
Page 84 and 85:
WO08141227 OR WO08098789 OR WO09047
Page 86 and 87:
US7754718 OR WO10077317 OR US201017
Page 88 and 89:
US2009075939 OR US2009074721 OR US2
Page 90 and 91:
US2006099170 OR EP1219605 OR CN1768
Page 92 and 93:
OR US7632853 OR WO9746222 OR US7364
Page 94 and 95:
161 PN=(WO2007071055 OR US5747490 o
Page 96 and 97:
Total PatentAuthor
Page 98 and 99:
Thomson InnovationCollection: US Gr
Page 100 and 101:
STN- Transcript of Search History=>
Page 102 and 103:
=> s l3S L3 SSS SAM FILE=REGISTRYSA
Page 105:
For more information contact WIPO a
show all

Patent Landscape Report on Ritonavir - WIPO

Create successful ePaper yourself

Delete template?

Save as template?